DNTH 2026-08-25 Dianthus Therapeutics: The C1s Shakeout Strengthens The Bull Case
Dianthus Therapeutics has $1.2 billion to fund claseprubart and other late-stage neuromuscular programs through 2030, with key readouts…
Equity Eagle 1 clickNASDAQ
Dianthus Therapeutics, Inc.
DNTH
1 story
$4.9B Market cap · 2026-10-06
DNTH 2026-08-25 Equity Eagle 1 click